New intracellular targets for therapeutic drug design.
ARIAD Pharmaceuticals, Inc., Cambridge, MA 02139-4234.
J S
JS
Brugge
D001665:Binding Sites; D015195:Drug Design; D006133:Growth Substances / Q000378:metabolism; D006801:Humans; D010455:Peptides / Q000737:chemistry / Q000378:metabolism* / Q000627:therapeutic use; D011506:Proteins / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000378:metabolism; D015398:Signal Transduction
D006133:Growth Substances; D010455:Peptides; D011506:Proteins; D011956:Receptors, Cell Surface